REQUEST A DEMO
Total
USD $0.00
Search more companies

Luoxin Pharmaceuticals Group Stock Co., Ltd. (China)

Main Activities: Measuring, Dispensing, and Other Pumping Equipment Manufacturing
Full name: Luoxin Pharmaceuticals Group Stock Co., Ltd. Profile Updated: March 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Luoxin Pharmaceuticals Group Stock Co., Ltd. (stock code: 002793) is a large pharmaceutical enterprise group that specializes in drug research and development, production, trade, and medical health services. The company has been consistently ranked among the top 100 pharmaceutical companies in China since 2006 and has been recognized as the best industrial enterprise in China's pharmaceutical research and development product line since 2011. It is a national industrial quality benchmark enterprise, a national key high-tech enterprise, and a national technology innovation demonstration enterprise. The company adheres to the strategic policy of "promoting enterprise through science and technology" and has established a research center in Shanghai Zhangjiang High-tech Park. The research center is staffed by a team of high-end scientific and technological talents from both domestic and international sources. With the advantages of various resources in Zhangjiang High-tech Park, the research center undertakes the research and development of high-tech projects and the cultivation of high-tech talents for the group, forming a three-in-one research system with the headquarters, which further promotes the development of new drugs. The company has a nationally recognized enterprise technology center, a national-local joint engineering laboratory, a national postdoctoral research workstation, a "Taishan Scholar Pharmaceutical Special Expert" position, a Shandong Province enterprise academician workstation, a Shandong Province freeze-dried powder injection drug engineering technology research center, a Shandong Province freeze-dried powder injection drug engineering laboratory, and a Shandong Province freeze-dried powder injection drug key laboratory. It has also established the Luoxin Pharmaceuticals Postdoctoral Mobile Workstation, teaching and training bases, internship bases, and employment bases at Shenyang Pharmaceutical University, forming a strong national-level research and technology center, injecting vitality into the rapid development of the company.

Headquarters
South Of Dashi First Class Highway Daxi Town Wenling City Zhejiang
Linyi; Shandong; Postal Code: 201210

Contact Details: Purchase the Luoxin Pharmaceuticals Group Stock Co., Ltd. report to view the information.

Website: http://www.luoxin.cn

Basic Information
Total Employees:
Purchase the Luoxin Pharmaceuticals Group Stock Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Luoxin Pharmaceuticals Group Stock Co., Ltd. report to view the information.
Registered Capital:
Purchase the Luoxin Pharmaceuticals Group Stock Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Luoxin Pharmaceuticals Group Stock Co., Ltd. report to view the information.
Incorporation Date:
May 11, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
21.79%
Purchase this report to view the information.
9.22%
Purchase this report to view the information.
4.29%
Purchase this report to view the information.
3.83%
Purchase this report to view the information.
3.29%
Subsidiaries
Luoxin Health Technology Development (Shanghai) Co., Ltd.
100%
Shandong Luoxin Pharmaceutical Sales Co., Ltd.
100%
Chengdu Medixin International Trade Co., Ltd.
99.65%
Company Performance
Financial values in the chart are available after Luoxin Pharmaceuticals Group Stock Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-51.5%
Total operating revenue
-51.5%
Operating profit (EBIT)
55.38%
Net Profit (Loss) for the Period
40.74%
Total assets
-39.43%
Total equity
-28.71%
Operating Profit Margin (ROS)
0.93%
Net Profit Margin
-2.87%
Return on Equity (ROE)
1.9%
Debt to Equity Ratio
-25.13%
Quick Ratio
-0.14%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?